Stay updated with breaking news from Pharmaceutical Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AGX-148is under clinical development by AgonOx and currently in Phase I for Head And Neck Cancer Squamous Cell Carcinoma.
Streptococcus vaccineis under clinical development by Minervax and currently in Phase I for Streptococcal Infections.
Crenigacestatis under clinical development by Eli Lilly and Co and currently in Phase I for Chronic Lymphocytic Leukemia (CLL).
Vofatamabis under clinical development by Fusion Pharmaceuticals and currently in Phase I for Relapsed Multiple Myeloma.
EBI-031is under clinical development by CTx Operations and currently in Phase III for Uveitis.